The Patient Remote Intervention and Symptom Management System (PRISMS): a telehealth mediated nurse-led intervention to enable real time monitoring and better management of chemotherapy side-effects in haematological cancer patients.

Not Applicable

• Conditions: Monitoring symptoms in haematological cancer patients; Lymphoma (non Hodgkin's lymphoma) - Low grade lymphoma; Leukaemia - Chronic leukaemia; Hodgkin's; Cancer - Lymphoma (non Hodgkin's lymphoma) - Low grade lymphoma; Cancer - Leukaemia - Chronic leukaemia; Cancer - Hodgkin's

• Registration Number: ACTRN12614000516684
• Lead Sponsor: Peter MacCallum Cancer Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-05-15
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 222

Inclusion Criteria

Have a diagnosis of one of three haematological cancers (Hodgkin's lymphoma, Non-hodgkin's lymphoma or Chronic Lymphocytic Leukemia)
Be receiving four or more cycles of chemotherapy treatment Be over 18 years of age

Exclusion Criteria

Having a key cognitive psychological disorder as assessed by the treatment team
Unable to speak/read/write English
Participating in a clinical drug trial

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The first primary outcomes is nausea of at least 0.4 standard deviations as measured by the Rotterdam Symptom Checklist. [Mid-cycle 4 of chemotherapy treatment];The second primary outcome is mucositis of at least 0.4 standard deviations as measured by the Rotterdam Symptom Checklist. [Mid-cycle 4 of chemotherapy treatment];The third primary outcome is constipation of at least 0.4 standard deviations as measured by the Rotterdam Symptom Checklist. [Mid-cycle 4 of chemotherapy treatment]